{"pmid":32425294,"pmcid":"PMC7227559","title":"Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes.","text":["Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes.","A subset of patients with severe COVID-19 develop profound inflammation and multi-organ dysfunction consistent with a \"Cytokine Storm Syndrome\" (CSS). In this review we compare the clinical features, diagnosis, and pathogenesis of COVID-CSS with other hematological CSS, namely secondary hemophagocytic lymphohistiocytosis (sHLH), idiopathic multicentric Castleman disease (iMCD), and CAR-T cell therapy associated Cytokine Release Syndrome (CRS). Novel therapeutics targeting cytokines or inhibiting cell signaling pathways have now become the mainstay of treatment in these CSS. We review the evidence for cytokine blockade and attenuation in these known CSS as well as the emerging literature and clinical trials pertaining to COVID-CSS. Established markers of inflammation as well as cytokine levels are compared and contrasted between these four entities in order to establish a foundation for future diagnostic criteria of COVID-CSS.","Blood Rev","England, James T","Abdulla, Alym","Biggs, Catherine M","Lee, Agnes Y Y","Hay, Kevin A","Hoiland, Ryan L","Wellington, Cheryl L","Sekhon, Mypinder","Jamal, Shahin","Shojania, Kamran","Chen, Luke Y C","32425294"],"abstract":["A subset of patients with severe COVID-19 develop profound inflammation and multi-organ dysfunction consistent with a \"Cytokine Storm Syndrome\" (CSS). In this review we compare the clinical features, diagnosis, and pathogenesis of COVID-CSS with other hematological CSS, namely secondary hemophagocytic lymphohistiocytosis (sHLH), idiopathic multicentric Castleman disease (iMCD), and CAR-T cell therapy associated Cytokine Release Syndrome (CRS). Novel therapeutics targeting cytokines or inhibiting cell signaling pathways have now become the mainstay of treatment in these CSS. We review the evidence for cytokine blockade and attenuation in these known CSS as well as the emerging literature and clinical trials pertaining to COVID-CSS. Established markers of inflammation as well as cytokine levels are compared and contrasted between these four entities in order to establish a foundation for future diagnostic criteria of COVID-CSS."],"journal":"Blood Rev","authors":["England, James T","Abdulla, Alym","Biggs, Catherine M","Lee, Agnes Y Y","Hay, Kevin A","Hoiland, Ryan L","Wellington, Cheryl L","Sekhon, Mypinder","Jamal, Shahin","Shojania, Kamran","Chen, Luke Y C"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425294","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.blre.2020.100707","keywords":["covid-19","cytokine release syndrome","cytokine storm syndrome","hemophagocytic lymphohistiocytosis","idiopathic multicentric castleman disease","severe acute respiratory syndrome coronavirus -2 (sars-cov-2)"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667252837925519360,"score":9.490897,"similar":[{"pmid":32451352,"title":"SARS-CoV-2: Viral Mechanisms and Possible Therapeutic Targets - What to learn from Rheumatologists?","text":["SARS-CoV-2: Viral Mechanisms and Possible Therapeutic Targets - What to learn from Rheumatologists?","It was with great interest that we read the letter from Randy Cron and collaborators ((1)) linking the cytokine storm syndrome (CSS) seen in macrophage activation syndrome, common in the rheumatological setting, with the CSS postulated to be a background in the novel coronavirus (SARS-CoV-2) infection. Amid the high contagiousness of the virus, science was also infected by an infodemia, compelled to enter a race to find effective therapies studying mechanisms molecular aspects of SARS-CoV-2 concomitant to urgent bedside manage of patients.","J Rheumatol","Mouraa, Carlos Antonio","Cerqueira de Sant'Ana Costa, Ana Luisa","32451352"],"abstract":["It was with great interest that we read the letter from Randy Cron and collaborators ((1)) linking the cytokine storm syndrome (CSS) seen in macrophage activation syndrome, common in the rheumatological setting, with the CSS postulated to be a background in the novel coronavirus (SARS-CoV-2) infection. Amid the high contagiousness of the virus, science was also infected by an infodemia, compelled to enter a race to find effective therapies studying mechanisms molecular aspects of SARS-CoV-2 concomitant to urgent bedside manage of patients."],"journal":"J Rheumatol","authors":["Mouraa, Carlos Antonio","Cerqueira de Sant'Ana Costa, Ana Luisa"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32451352","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3899/jrheum.200657","locations":["Rheumatologists"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667881798388940800,"score":432.9427},{"pmid":32335512,"title":"Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs.","text":["Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs.","We read with interest the Editorial by Cron and Chatam (1) suggesting a cytokine storm syndrome (CSS) occurring in response to SARS-CoV-2 infection and, consequently, a possible role for targeted approaches to blocking inflammatory cytokines.","J Rheumatol","Filocamo, Giovanni","Minoia, Francesca","Carbogno, Simone","Costi, Stefania","Romano, Micol","Cimaz, Rolando","32335512"],"abstract":["We read with interest the Editorial by Cron and Chatam (1) suggesting a cytokine storm syndrome (CSS) occurring in response to SARS-CoV-2 infection and, consequently, a possible role for targeted approaches to blocking inflammatory cytokines."],"journal":"J Rheumatol","authors":["Filocamo, Giovanni","Minoia, Francesca","Carbogno, Simone","Costi, Stefania","Romano, Micol","Cimaz, Rolando"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335512","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.3899/jrheum.200483","topics":["Treatment"],"weight":1,"_version_":1666138494123114496,"score":405.82162},{"pmid":32438839,"title":"Is there a role for blood purification therapies targeting cytokine storm syndrome in critically severe COVID-19 patients?","text":["Is there a role for blood purification therapies targeting cytokine storm syndrome in critically severe COVID-19 patients?","The coronavirus disease-19 (COVID-19) has spread over many countries and regions since the end of 2019, becoming the most severe public health event at present. Most of the critical cases developed multiple organ dysfunction, including acute kidney injury (AKI). Cytokine storm syndrome (CSS) may complicate the process of severe COVID-19 patients. This manuscript reviews the different aspects of blood purification in critically ill patients with AKI and increased inflammatory factors, and examines its potential role in severe COVID-19 treatment. Continuous renal replacement therapy (CRRT) has been practiced in many sepsis patients with AKI. Still, the timing and dosing need further robust evidence. In addition to the traditional CRRT, the high-throughput membrane with adsorption function and cytokine adsorption column are two representatives of recently emerging novel membrane technologies. Their potential in removing inflammatory factors and other toxins prospects for the treatment of severe COVID-19.","Ren Fail","Chen, Gang","Zhou, Yangzhong","Ma, Jie","Xia, Peng","Qin, Yan","Li, Xuemei","32438839"],"abstract":["The coronavirus disease-19 (COVID-19) has spread over many countries and regions since the end of 2019, becoming the most severe public health event at present. Most of the critical cases developed multiple organ dysfunction, including acute kidney injury (AKI). Cytokine storm syndrome (CSS) may complicate the process of severe COVID-19 patients. This manuscript reviews the different aspects of blood purification in critically ill patients with AKI and increased inflammatory factors, and examines its potential role in severe COVID-19 treatment. Continuous renal replacement therapy (CRRT) has been practiced in many sepsis patients with AKI. Still, the timing and dosing need further robust evidence. In addition to the traditional CRRT, the high-throughput membrane with adsorption function and cytokine adsorption column are two representatives of recently emerging novel membrane technologies. Their potential in removing inflammatory factors and other toxins prospects for the treatment of severe COVID-19."],"journal":"Ren Fail","authors":["Chen, Gang","Zhou, Yangzhong","Ma, Jie","Xia, Peng","Qin, Yan","Li, Xuemei"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32438839","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1080/0886022X.2020.1764369","keywords":["covid-19","cytosorb","acute kidney injury","blood purification","cytokine storm","oxiris"],"topics":["Treatment"],"weight":1,"_version_":1667535119564406784,"score":377.28052},{"pmid":32335514,"title":"The Question of Whether to Remain on Therapy for Chronic Rheumatic Diseases in the Setting of the Covid-19 Pandemic.","text":["The Question of Whether to Remain on Therapy for Chronic Rheumatic Diseases in the Setting of the Covid-19 Pandemic.","We appreciate our Italian colleagues' interest in our editorial denoting the rheumatologist's role in helping to diagnose and treat cytokine storm syndrome (CSS) in the setting of the Covid-19 panemic (1). It is encouraging that none of the 123 pediatric rheumatology patients (primarily juvenile idiopathic arthritis) on background biological disease modifying anti-rheumatic drug (bDMARD) therapies in Milan, Italy surveyed over a 7-week period from February 25 through April 14, 2020 (during which time Covid-19 was hyper-endemic there) had either confirmed or suspected Covid-19 (2).","J Rheumatol","Cron, Randy Q","Chatham, W Winn","32335514"],"abstract":["We appreciate our Italian colleagues' interest in our editorial denoting the rheumatologist's role in helping to diagnose and treat cytokine storm syndrome (CSS) in the setting of the Covid-19 panemic (1). It is encouraging that none of the 123 pediatric rheumatology patients (primarily juvenile idiopathic arthritis) on background biological disease modifying anti-rheumatic drug (bDMARD) therapies in Milan, Italy surveyed over a 7-week period from February 25 through April 14, 2020 (during which time Covid-19 was hyper-endemic there) had either confirmed or suspected Covid-19 (2)."],"journal":"J Rheumatol","authors":["Cron, Randy Q","Chatham, W Winn"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335514","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.3899/jrheum.200492","locations":["Italian","Milan","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1666138494100045825,"score":371.16068},{"pmid":32408047,"title":"Development and initial validation of the COVID Stress Scales.","text":["Development and initial validation of the COVID Stress Scales.","Research and clinical observations suggest that during times of pandemic many people exhibit stress- or anxiety-related responses that include fear of becoming infected, fear of coming into contact with possibly contaminated objects or surfaces, fear of foreigners who might be carrying infection (i.e., disease-related xenophobia), fear of the socio-economic consequences of the pandemic, compulsive checking and reassurance-seeking regarding possible pandemic-related threats, and traumatic stress symptoms about the pandemic (e.g., nightmares, intrusive thoughts). We developed the 36-item COVID Stress Scales (CSS) to measure these features, as they pertain to COVID-19. The CSS were developed to better understand and assess COVID-19-related distress. The scales were intentionally designed so they could be readily adapted for future pandemics. The CSS were developed and initially validated in population-representative samples from Canada (N = 3479) and the United States (N = 3375). A stable 5-factor solution was identified, corresponding to scales assessing COVID-related stress and anxiety symptoms: (1) Danger and contamination fears, (2) fears about economic consequences, (3) xenophobia, (4) compulsive checking and reassurance seeking, and (5) traumatic stress symptoms about COVID-19. The scales performed well on various indices of reliability and validity. The scales were intercorrelated, providing evidence of a COVID Stress Syndrome. The scales offer promise as tools for better understanding the distress associated with COVID-19 and for identifying people in need of mental health services.","J Anxiety Disord","Taylor, Steven","Landry, Caeleigh A","Paluszek, Michelle M","Fergus, Thomas A","McKay, Dean","Asmundson, Gordon J G","32408047"],"abstract":["Research and clinical observations suggest that during times of pandemic many people exhibit stress- or anxiety-related responses that include fear of becoming infected, fear of coming into contact with possibly contaminated objects or surfaces, fear of foreigners who might be carrying infection (i.e., disease-related xenophobia), fear of the socio-economic consequences of the pandemic, compulsive checking and reassurance-seeking regarding possible pandemic-related threats, and traumatic stress symptoms about the pandemic (e.g., nightmares, intrusive thoughts). We developed the 36-item COVID Stress Scales (CSS) to measure these features, as they pertain to COVID-19. The CSS were developed to better understand and assess COVID-19-related distress. The scales were intentionally designed so they could be readily adapted for future pandemics. The CSS were developed and initially validated in population-representative samples from Canada (N = 3479) and the United States (N = 3375). A stable 5-factor solution was identified, corresponding to scales assessing COVID-related stress and anxiety symptoms: (1) Danger and contamination fears, (2) fears about economic consequences, (3) xenophobia, (4) compulsive checking and reassurance seeking, and (5) traumatic stress symptoms about COVID-19. The scales performed well on various indices of reliability and validity. The scales were intercorrelated, providing evidence of a COVID Stress Syndrome. The scales offer promise as tools for better understanding the distress associated with COVID-19 and for identifying people in need of mental health services."],"journal":"J Anxiety Disord","authors":["Taylor, Steven","Landry, Caeleigh A","Paluszek, Michelle M","Fergus, Thomas A","McKay, Dean","Asmundson, Gordon J G"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32408047","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.janxdis.2020.102232","keywords":["anxiety","covid-19","coronavirus","fear","pandemic","stress","xenophobia"],"locations":["Canada","United States"],"countries":["Canada","United States"],"countries_codes":["CAN|Canada","USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666802845314187264,"score":356.86234}]}